Verdence Capital Advisors’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
UCFA
VCM
VPM
MC
Verdence Capital Advisors's RGEN Position: Q1 2026 in Review
Verdence Capital Advisors increased its Repligen (RGEN) stake by 6.8% in Q1 2026, buying an estimated $36.3K and bringing the position to 4,062 shares worth $479K. The position accounts for 0.03% of the portfolio, ranked #437.
Verdence Capital Advisors first reported a position in RGEN in Q2 2023 and has held it in 12 quarters since. The position peaked at $791K in Q3 2025. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.
- Verdence Capital Advisors held 4,062 shares of Repligen worth $479K as of Q1 2026.
- Verdence Capital Advisors bought 260 Repligen shares in Q1 2026, an estimated $36.3K.
- Repligen made up 0.03% of Verdence Capital Advisors's portfolio in Q1 2026, its #437 holding.
- Verdence Capital Advisors first reported a position in Repligen in Q2 2023 and has held it in 12 quarters since.
- Verdence Capital Advisors's Repligen position peaked at $791K in Q3 2025.
- 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.
Based on Verdence Capital Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.